Patents Assigned to Orygen Youth Health Research Centre
  • PREVENTION OF PSYCHOTIC DISORDERS AND/OR TREATMENT OF PSYCHOTIC SYMPTOMS
    Publication number: 20210251936
    Abstract: The present invention relates to methods of preventing a psychotic disorder in a subject in need of intervention including administering to the subject a composition including EPA (eicosapentanoic acid) and DHA (docosahexaenoic acid). Methods of treating pre-psychotic symptoms in a subject, including administering to the subject a composition including EPA and DHA are also included.
    Type: Application
    Filed: May 3, 2021
    Publication date: August 19, 2021
    Applicant: Orygen Youth Health Research Centre
    Inventors: Gunter Paul Amminger, Patrick Dennistoun McGorry
  • Prevention of psychotic disorders and/or treatment of psychotic symptoms
    Patent number: 11013708
    Abstract: The present invention relates to methods of preventing a psychotic disorder in a subject in need of intervention including administering to the subject a composition including EPA (eicosapentanoic acid) and DHA (docosahexaenoic acid). Methods of treating pre-psychotic symptoms in a subject, including administering to the subject a composition including EPA and DHA are also included.
    Type: Grant
    Filed: May 9, 2019
    Date of Patent: May 25, 2021
    Assignee: Orygen Youth Health Research Centre
    Inventors: Gunter Paul Amminger, Patrick Dennistoun McGorry
  • PREVENTION OF PSYCHOTIC DISORDERS AND/OR TREATMENT OF PSYCHOTIC SYMPTOMS
    Publication number: 20190321320
    Abstract: The present invention relates to methods of preventing a psychotic disorder in a subject in need of intervention including administering to the subject a composition including EPA (eicosapentanoic acid) and DHA (docosahexaenoic acid). Methods of treating pre-psychotic symptoms in a subject, including administering to the subject a composition including EPA and DHA are also included.
    Type: Application
    Filed: May 9, 2019
    Publication date: October 24, 2019
    Applicant: Orygen Youth Health Research Centre
    Inventors: Gunter Paul Amminger, Patrick Dennistoun McGorry
  • Prevention of psychotic disorders and/or treatment of psychotic symptoms
    Patent number: 10314805
    Abstract: The present invention relates to methods of preventing a psychotic disorder in a subject in need of intervention including administering to the subject a composition including EPA (eicosapentanoic acid) and DHA (docosahexaenoic acid). Methods of treating pre-psychotic symptoms in a subject, including administering to the subject a composition including EPA and DHA are also included.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: June 11, 2019
    Assignee: Orygen Youth Health Research Centre
    Inventors: Gunter Paul Amminger, Patrick Dennistoun McGorry
  • PREVENTION OF PSYCHOTIC DISORDERS AND/OR TREATMENT OF PSYCHOTIC SYMPTOMS
    Publication number: 20180104209
    Abstract: The present invention relates to methods of preventing a psychotic disorder in a subject in need of intervention including administering to the subject a composition including EPA (eicosapentanoic acid) and DHA (docosahexaenoic acid). Methods of treating pre-psychotic symptoms in a subject, including administering to the subject a composition including EPA and DHA are also included.
    Type: Application
    Filed: December 15, 2017
    Publication date: April 19, 2018
    Applicant: Orygen Youth Health Research Centre
    Inventors: Gunter Paul Amminger, Patrick Dennistoun McGorry
  • Prevention of psychotic disorders and/or treatment of psychotic symptoms
    Patent number: 9884034
    Abstract: The present invention relates to methods of preventing a psychotic disorder in a subject in need of intervention including administering to the subject a composition including EPA (eicosapentanoic acid) and DHA (docosahexaenoic acid). Methods of treating pre-psychotic symptoms in a subject, including administering to the subject a composition including EPA and DHA are also included.
    Type: Grant
    Filed: May 5, 2014
    Date of Patent: February 6, 2018
    Assignee: Orygen Youth Health Research Centre
    Inventors: Gunter Paul Amminger, Patrick Dennistoun McGorry
  • PREVENTION OF PSYCHOTIC DISORDERS AND/OR TREATMENT OF PSYCHOTIC SYMPTOMS
    Publication number: 20140323571
    Abstract: The present invention relates to methods of preventing a psychotic disorder in a subject in need of intervention including administering to the subject a composition including EPA (eicosapentanoic acid) and DHA (docosahexaenoic acid). Methods of treating pre-psychotic symptoms in a subject, including administering to the subject a composition including EPA and DHA are also included.
    Type: Application
    Filed: May 5, 2014
    Publication date: October 30, 2014
    Applicant: Orygen Youth Health Research Centre
    Inventors: Gunter Paul Amminger, Patrick Dennistoun McGorry